The recall affects around 14.76 lakh bottles of Atomoxetine Capsules in various strengths, produced by Glenmark ...
Glenmark Pharmaceuticals is recalling 15 lakh bottles of Atomoxetine Capsules in the US due to an N-Nitroso Atomoxetine ...
Glenmark Pharmaceuticals recalls 14.76 lakh bottles of Atomoxetine Capsules in the US due to impurity concerns.
Glenmark Pharmaceuticals is recalling close to 15 lakh bottles of a generic medication used in the treatment of attention ...
Glenmark Pharmaceuticals, a global pharmaceutical giant, is recalling nearly 15 lakh bottles of Atomoxetine capsules from the ...
Glenmark Pharmaceuticals Inc, USA, an arm of the Mumbai-based Glenmark Pharmaceuticals, is recalling around 14.76 lakh ...
According to the U.S. health agency, Glenmark Pharmaceuticals is recalling over 15 lakh bottles of a generic drug used to ...
ADHD is a neurodevelopmental disorder that affects a person's ability to focus, control impulses, and regulate their activity ...
As national pressure mounts for some medications for the mind, the FDA reveals a question that arose for a major pharmaceutical manufacturer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback